David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
David Goodman
Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Mahamat Djalal · Conseiller principal du Québec, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Éric Sabourin · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
catherine Martinelli · Business Risk Analyst, Innovation, Science and Economic Development Canada (ISED)
Alhadji Mamat · Gestionnaire princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Jacques Ramsay · Député
Marjorie Michel · Ministre de la Santé, Health Canada (HC)
Alizée Rivalta · Adjointe aux communications, House of Commons
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
and 2 more Show fewer
Fatoumata Bah · Conseillere en politiques, Health Canada (HC)
Mahamat Djalal · Conseiller principal du Québec, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Éric Sabourin · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Erin Campbell · Directrice, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Jean-Sébastien Côté · Gestionnaire de bureau, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Jean-Sébastien Côté · Gestionnaire de bureau, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Justine Frame · Conseillère en politiques, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Éric Sabourin · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Éric Sabourin · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Kathy Frankiewicz · adjointe administrative, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Policies aimed at facilitating generic drug repurposing.
Official report
Justine Frame · Conseillère en politiques, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Justine Frame · Conseillère en politiques, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Élyse Moisan · Conseiller politique, Finance Canada (FIN)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
← Newer
Page 2
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.